FREE Case Review (866) 588-0600

South Carolina Mounjaro Stomach Paralysis Lawsuit (2024 Update)

Awards & recognition
C.L. Mike Schmidt Published by C.L. Mike Schmidt
Free Confidential Mounjaro Stomach Paralysis Lawsuit Review
If you or a loved one suffered from stomach paralysis or another injury after taking Mounjaro or another weight loss medication, you should contact our lawyers today.

You may be entitled to compensation by filing a Mounjaro Stomach Paralysis Lawsuit and our lawyers can help. Please click the button below for a Free Confidential Case Evaluation or call our law firm today by dialing (866) 588-0600.

Start My Free Case Review

Quick Summary

  • In South Carolina, patients are seeking justice in courts due to severe stomach paralysis allegedly caused by the diabetes medication Mounjaro. Similar severe side effects, such as stomach paralysis, have also been reported with the diabetes drug Ozempic, shedding light on ongoing litigation against Novo Nordisk for severe gastrointestinal issues experienced by patients.
  • Understanding the gravity of these claims, we explore the legal battles surrounding the South Carolina Mounjaro stomach paralysis lawsuit and its implications for affected individuals and the pharmaceutical industry.
  • If you or someone you know has been affected by complications from Mounjaro, Schmidt & Clark, LLP, is here to assist you. Renowned for our proficiency in plaintiff representation, our main objective is to ensure you obtain the justice and compensation you rightfully deserve.

How S&C Can Help With Your Claim?

S&C can help with your claim by understanding the complexities and emotional toll that come with pursuing a lawsuit, especially one as intricate as the Mounjaro stomach paralysis case.

Our team of experienced attorneys is dedicated to guiding you through every step of the legal process, ensuring that you receive the support and representation you need.

We can help provide you with:

  • Comprehensive Case Evaluation
  • Personalized Legal Strategy
  • Aggressive Representation

Mounjaro Stomach Paralysis Lawsuit

In the Palmetto State, a storm has been brewing in courtrooms over a diabetes medication named Mounjaro. A number of South Carolina residents have taken legal action against the drug’s manufacturers, alleging a connection between their stomach paralysis, also known as gastroparesis, and their use of Mounjaro.

This medication, designed to regulate blood sugar levels, affects the GLP-1 receptor, a piece of the biological puzzle that’s been implicated in the development of this debilitating condition.

Here are the primary aspects of the lawsuit:

  1. Allegations: Plaintiffs claim that their severe stomach problems are directly linked to the use of Mounjaro.
  2. Approval and Reality: Although Mounjaro was approved for the treatment of type 2 diabetes, some patients experienced adverse effects instead of benefits.
  3. Legal Precedent: The outcomes of these lawsuits in South Carolina could set a significant precedent for future cases nationwide.

Similar diabetes drugs, including Ozempic and Wegovy, are also under scrutiny due to numerous cases of stomach paralysis.

As the legal proceedings mount, drug makers Eli Lilly and Novo Nordisk are pushed into the limelight:

  • Eli Lilly: Faces multiple lawsuits and seeks to avoid consolidated litigation.
  • Novo Nordisk: Attempts to dismiss the lawsuits related to Ozempic.

The multiplying effect of lawsuits related to Mounjaro and similar drugs signals that patient safety concerns are at the forefront of public consciousness. This trend has the potential to catalyze major changes in how diabetes and weight loss drugs are developed, marketed, and monitored post-approval.

What Is Mounjaro?

According to Healthline, Mounjaro is a new medication for managing type 2 diabetes. Eli Lilly developed the weight loss drug, which works by targeting the GLP-1 receptor, which is involved in regulating blood sugar levels [1].

By mimicking the effects of the GLP-1 hormone, Mounjaro helps to stimulate insulin production while simultaneously inhibiting the release of glucagon, a hormone that raises blood sugar levels.

One of Mounjaro’s notable aspects is its dual-action mechanism. Not only does it aid in controlling blood sugar, but it also impacts appetite regulation, which has led to its off-label use for weight loss.

This dual functionality has made it a popular choice among patients and healthcare providers alike despite the growing concerns over its side effects.

Was Mounjaro Recalled?

Mounjaro was not recalled, but its journey through the FDA approval process has been fraught with controversy. On May 13, 2022, the drug was approved for adult type 2 diabetes treatment after extensive clinical trials across multiple countries.

This approval was based on Mounjaro’s demonstrated ability to lower HbA1c levels, a key marker of blood sugar control.

Despite the initial fanfare, Mounjaro’s side effects, such as nausea and abdominal pain, quickly became a point of concern. Moreover, the drug received a boxed warning for an increased risk of gallbladder disease, a serious red flag for patient safety.

Similarly, the FDA has issued warnings regarding the diabetes medication Ozempic, particularly its potential link to rare but severe side effects like stomach paralysis and intestinal blockage (ileus).

According to Jama Network, there have been reported cases related to gastrointestinal issues among people taking medications like Ozempic for weight loss [2].

As a result of using the defendants’ Ozempic and Mounjaro, the plaintiff was caused to suffer from severe gastrointestinal events – Jennifer Chesak, MSJ, Medical Journalist for Healthline

Side Effects of Mounjaro: Stomach Paralysis

Stomach paralysis, or gastroparesis, is a serious medical condition where the stomach muscles slow down or stop working entirely, leading to delayed gastric emptying.

According to Mana, for those afflicted, the symptoms can be life-altering, including [3]:

  • Nausea and vomiting
  • Stomach pain
  • Bloating
  • Feeling full after only a few bites of food
  • Heartburn
  • Lack of appetite
  • Weight loss

It’s a condition that can make eating a meal a daunting task and can lead to serious medical complications if left unchecked.

The association between Mounjaro and gastroparesis is well-documented. Many patients who turned to the drug for diabetes control or weight loss now grapple with severe symptoms that require substantial medical intervention, including dietary modifications and therapies to stimulate stomach muscles.

Similar gastrointestinal issues have been reported with other receptor agonist medications, underscoring the potential side effects such as gastroparesis, ileus, and bowel obstruction.

These reports emphasize the critical need for rigorous drug vetting processes. The severe gastrointestinal issues experienced by Mounjaro users highlight the importance of caution when introducing new medications to the market.

The Status Of The Mounjaro Lawsuit Litigation in South Carolina

While South Carolina may be the focal point of the Mounjaro stomach paralysis controversy, the issue has spread across the United States.

Plaintiffs nationwide are alleging that Eli Lilly, the pharmaceutical company behind Mounjaro, did not provide sufficient warnings about the drug’s severe side effects, particularly gastroparesis. The legal scrutiny has also extended to include Ozempic, leading to numerous Ozempic lawsuits that highlight similar concerns about inadequate warnings and severe side effects.

Following Mounjaro’s release, reports of severe gastrointestinal side effects began to surface, leading to hospitalizations and emergency room visits. These incidents have sparked numerous lawsuits against not only Eli Lilly but also Novo Nordisk as legal scrutiny expands to include more diabetes medications.

Ozempic stomach paralysis lawsuits are also emerging, alleging severe gastrointestinal problems like stomach paralysis, vomiting, and delays in gastric emptying. These lawsuits are part of a growing movement demanding accountability from drug manufacturers.

The evolving landscape of Mounjaro-related litigation has led to the consolidation of lawsuits into multidistrict litigation (MDL) in South Carolina. As of mid-2024, the MDL for GLP-1 receptor agonist drugs, including Mounjaro, has over 100 pending cases, indicating a significant rise in litigation.

This consolidation aims to streamline the process for the numerous affected parties and ensure more efficient legal proceedings.

How Do You Qualify for a Mounjaro Stomach Paralysis Lawsuit?

To qualify for a Mounjaro stomach paralysis lawsuit, you must have experienced severe gastrointestinal symptoms, particularly gastroparesis, after being prescribed the medication.

You need to prove that these symptoms, such as severe vomiting, stomach or abdominal pain, bloating, and acid reflux, began after starting Mounjaro.

Additionally, similar to an Ozempic stomach paralysis claim, individuals who were prescribed Mounjaro and experienced gastrointestinal problems leading to hospitalization or were diagnosed with gastroparesis may qualify for a Mounjaro stomach paralysis lawsuit.

Similar to Mounjaro, individuals who were also prescribed Ozempic can file an Ozempic stomach paralysis lawsuit.

Mounjaro Lawsuit Settlement Amounts in South Carolina

In the aftermath of Mounjaro-related health issues, the pursuit of compensation becomes a beacon of hope for many affected individuals. Damages in a Mounjaro or Ozempic lawsuit may cover a wide range of impacts, from medical costs and lost wages to the intangible toll of pain and suffering.

Legal experts suggest that successful Mounjaro claims could lead to settlement amounts between $150,000 and $300,000. This range is not arbitrary; it reflects the plaintiffs’ economic and non-economic hardships.

Filing a Mounjaro Stomach Paralysis Lawsuit in South Carolina

Embarking on a legal journey in response to Mounjaro-related injuries involves several key steps. It typically starts with an initial consultation, where your attorney will review medical records and discuss the viability of your case.

Types of Evidence To Present

When pursuing a Mounjaro stomach paralysis lawsuit, presenting robust and compelling evidence is crucial to substantiate your claims and increase the likelihood of a favorable outcome.

Here are some key types of evidence that can significantly strengthen your case:

  • Medical Records: Comprehensive medical documentation is essential. This includes records of your diagnosis, treatment plans, hospital visits, and any procedures related to your gastrointestinal issues. Detailed notes from your healthcare providers about your symptoms and their progression are also vital.
  • Expert Testimonies: Engaging medical experts who can testify about the link between Mounjaro and your condition can be highly beneficial. These experts can provide professional insights into how the drug may have contributed to your symptoms, offering a credible and authoritative perspective.
  • Personal Testimonies: Your own account of how Mounjaro has affected your life can be powerful. This includes a detailed narrative of your symptoms, the impact on your daily activities, and the emotional toll of dealing with severe gastrointestinal issues.
  • Scientific Studies: Research and studies that highlight the potential side effects of Mounjaro and similar medications can support your claims by demonstrating a broader context of known risks.

By meticulously gathering and presenting these types of evidence, you can build a strong case that clearly illustrates the connection between Mounjaro and your stomach paralysis, thereby enhancing your chances of achieving a successful resolution in your lawsuit.

What is the Statute of Limitations for the Mounjaro Lawsuit in South Carolina?

The statute of limitations for the Mounjaro lawsuit in South Carolina is three years from the date of injury or discovery of the injury. Understanding this timeframe is crucial for anyone considering legal action.

This means that you have a limited window of time to initiate legal proceedings, and failing to file within this period can result in the forfeiture of your right to seek compensation.

Related Articles:

See all related dangerous drug lawsuits our attorneys covered so far.

Choose our lawyers

Have you or a loved one suffered from the adverse side effects caused by defective medication?

Get Your Free Consultation From Our South Carolina Lawyers

The Schmidt & Clark, LLP law firm is here to support you during these challenging times. If you or a loved one has suffered from gastrointestinal disorders due to weight loss drugs such as Mounjaro, don’t hesitate to reach out to us.

Our team has extensive experience handling such cases and will guide you through the legal proceedings. We will clarify your rights and assess your eligibility for a lawsuit related to these complications.

Get a free case evaluation, and remember, we only charge fees if we successfully win your case. You can trust that our commitment to your case is as strong as if you were part of our own family. Contact us today for a comprehensive review of your concerns.



Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.